Genentech Faces Threat From New Erbitux Data
1 CommentBy Ed Silverman // April 21st, 2008 // 7:27 am
• Pharma Blog » Archives
Avastin
Eyeing Coverage: Ontario Blinks Over Lucentis
2 CommentsBy Ed Silverman // March 14th, 2008 // 8:25 am
Friend Or Foe? The FDA’s Controversial Cancer Doc
3 CommentsBy Ed Silverman // March 12th, 2008 // 7:55 am
Congress: No Hearing On Lucentis Pricing
1 CommentBy Ed Silverman // February 27th, 2008 // 3:51 pm
BCA’s Brenner: Why Avastin Changes FDA Standards
2 CommentsBy Ed Silverman // February 26th, 2008 // 1:46 pm
FDA Approves Avastin For Breast Cancer
17 CommentsBy Ed Silverman // February 22nd, 2008 // 4:32 pm
Genentech’s Avastin Slows Spread Of Breast Cancer
2 CommentsBy Ed Silverman // February 13th, 2008 // 8:18 am
Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // January 28th, 2008 // 7:14 am
ImClone Stock Pops On Erbitux Results
Make a commentBy Ed Silverman // September 11th, 2007 // 4:25 pm